The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Exploratory analyses of immune reconstitution biomarkers from a Ph1b study of an investigational, oral, live biotherapeutic, SER-155, in adult allo-HCT.
 
Emily Walsh
Employment - Seres Therapeutics
Stock and Other Ownership Interests - Seres Therapeutics
Research Funding - Seres Therapeutics (Inst)
 
Jonathan Peled
Employment - Memorial Sloan-Kettering Cancer Center
Stock and Other Ownership Interests - Postbiotics Inc.; Seres Therapeutics
Consulting or Advisory Role - CSL Behring; Da Volterra; MaaT Pharma; Prodigy Biotech
Research Funding - Seres Therapeutics
Travel, Accommodations, Expenses - Seres Therapeutics
 
Doris Ponce
Consulting or Advisory Role - ceramedix; Generon; Incyte; Sanofi
Research Funding - Incyte; Sanofi; Takeda (Inst)
 
Satyajit Kosuri
No Relationships to Disclose
 
Nandita Khera
No Relationships to Disclose
 
David Lichter
Employment - Seres Therapeutics
Stock and Other Ownership Interests - Abbott; Abbvie; Agilent; Baxter; BD Biosciences; Bluebird Bio; Blueprint Medicines; Bristol Myers Squibb Foundation; Seres Therapeutics
 
Kelly Brady
Employment - Kelly Brady
Stock and Other Ownership Interests - Seres Therapeutics
Research Funding - Seres Therapeutics
Travel, Accommodations, Expenses - Seres Therapeutics
 
Brooke Hasson
Employment - Seres Therapeutics
Stock and Other Ownership Interests - Seres Therapeutics
 
Swarna Pandian
Employment - Seres Therapeutics
Stock and Other Ownership Interests - Seres Therapeutics
Research Funding - Seres Therapeutics
 
Nathan Hicks
Employment - Seres Therapeutics
Stock and Other Ownership Interests - Seres Therapeutics
 
Meghan Chafee
Employment - Seres Therapeutics
Stock and Other Ownership Interests - Seres Therapeutics
 
Elizabeth Halvorsen
Employment - Seres Therapeutics
Stock and Other Ownership Interests - Seres Therapeutics
 
Mary-Jane Lombardo
Employment - Prolacta Bioscience (I); Seres Therapeutics
Stock and Other Ownership Interests - Seres Therapeutics
 
Christopher Ford
Employment - Seres Therapeutics
Stock and Other Ownership Interests - Seres Therapeutics
 
Bina Tejura
Employment - Seres Therapeutics
Stock and Other Ownership Interests - Seres Therapeutics
Research Funding - Seres Therapeutics
Travel, Accommodations, Expenses - Seres Therapeutics
Other Relationship - Seres Therapeutics
 
Matthew Henn
Employment - Seres Therapeutics
Stock and Other Ownership Interests - Seres Therapeutics
Research Funding - Seres Therapeutics
Travel, Accommodations, Expenses - Seres Therapeutics
 
Lisa von Moltke
Employment - Seres Therapeutics
Leadership - Cara Therapeutics; Seres Therapeutics
Stock and Other Ownership Interests - Cara Therapeutics; Seres Therapeutics
 
Marcel van den Brink
Leadership - Smart Immune
Stock and Other Ownership Interests - Seres Therapeutics; Thymofox
Honoraria - BeiGene (I); Cellectar (I); Ceramedix; Da Volterra; Forty Seven; Frazier Healthcare Partners; Garuda Therapeutics; GlaxoSmithKline; Kite, a Gilead company (I); Lygenesis; Magenta Therapeutics; Merck; MustangBio (I); Nektar; Notch Therapeutics; Novartis (I); Pluto Immunotherapeutics; Priothera; Rheos Medicines; Rheos Medicines; Seres Therapeutics; Synthekine (I); Thymofox; Vor Biopharma; WindMIL; WindMIL
Consulting or Advisory Role - Seres Therapeutics
Research Funding - Seres Therapeutics
Patents, Royalties, Other Intellectual Property - Dr. van den Brink receives royalties from Wolters Kluwer, and he has intellectual property Licensing with Seres Therapeutics and Juno Therapeutics
Travel, Accommodations, Expenses - Rheos Medicines
Other Relationship - DKMS
(OPTIONAL) Uncompensated Relationships - Notch Therapeutics; Pluto Immunotherapeutics; Seres therapeutics
 
Zachariah DeFilipp
Consulting or Advisory Role - Incyte; Inhibrx; MorphoSys; Ono Pharmaceutical; PharmaBiome; Sanofi
Research Funding - Incyte; REGiMMUNE; Taiho Oncology
 
Seres Therapeutics SER-155 Team
No Relationships to Disclose